246 filings
8-K
BGNE
BeiGene Ltd
20 Mar 24
Departure of Directors or Certain Officers
4:10pm
8-K
BGNE
BeiGene Ltd
15 Mar 24
BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy
4:52pm
8-K
BGNE
BeiGene Ltd
8 Mar 24
Other Events
6:01am
8-K
BGNE
BeiGene Ltd
26 Feb 24
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
6:02am
8-K
BGNE
BeiGene Ltd
23 Jan 24
BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors
6:03am
8-K
biafkg 21cwxea9
8 Dec 23
Other Events
6:01am
8-K
zypkvi8s10f67
9 Nov 23
BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates
4:08pm
8-K
qppuf2ms2jfp3ogt
20 Oct 23
BRUKINSA® Receives Positive Recommendation from NICE in U.K. for Adult Patients with Chronic Lymphocytic Leukemia
4:04pm
8-K
br3o7f6523i39wns
21 Sep 23
Other Events
4:04pm
8-K
kbrq29n 4e5b4fj883sv
19 Sep 23
Termination of a Material Definitive Agreement
6:01am
8-K
735kbuk07
29 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
fh1k cslp6cpm7m6xm8m
2 Aug 23
BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results
6:13am
8-K
fke xk201h7
24 Jul 23
BeiGene Announces Positive CHMP Opinion for Tislelizumab as a Treatment for Advanced or Metastatic ESCC
4:13pm
8-K
lduaxa15evwng65s53ac
11 Jul 23
Termination of a Material Definitive Agreement
6:01am
8-K
y0id686t2ckza7v 2k
15 Jun 23
BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congress
4:43pm
8-K
9qn6d74w9cv6y
26 May 23
BeiGene Presentations at the 2023 ASCO Annual Meeting Reinforce Promise Across Oncology Portfolio
4:04pm
8-K
6qki4hgdzc x12ohx1e
8 May 23
BeiGene Receives New Approvals for BRUKINSA® (zanubrutinib) in China
4:05pm
8-K
ttp tcgmp
4 May 23
BeiGene Reports First Quarter 2023 Financial Results and Corporate Developments
7:07am
8-K
2lxc8h uq6t
25 Apr 23
Results of Operations and Financial Condition
4:15pm
8-K
6w4j34z2imkgfq
20 Apr 23
BeiGene Announces Positive Phase 3 Tislelizumab Trial in Advanced Gastric or
4:01pm